Changes in hippocampal GABAA receptor subunit composition in bipolar 1 disorder

Molecular Brain Research

Volumn 138, Issue 2, 2005, Pages 145-155

  Dean, Brian ^a,b,c   Scarr, Elizabeth ^a,b   McLeod, Mark ^a,b  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

GABAA receptor; Hippocampus; Human; Postmortem; Schizophrenia

Indexed keywords

3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPIN 2 ONE DERIVATIVE; CHLORPROMAZINE; CLONAZEPAM; CLOZAPINE; DIAZEPAM; FLUMAZENIL; FLUPENTIXOL; FLUPHENAZINE; FLUPHENAZINE DECANOATE; LORAZEPAM; MUSCIMOL; NITRAZEPAM; PIMOZIDE; RADIOLIGAND; RECEPTOR SUBUNIT; RISPERIDONE; TEMAZEPAM; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE; TRITIUM; ZOLPIDEM; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; PROTEIN SUBUNIT; PYRIDINE DERIVATIVE;

ADULT; AGED; ARTICLE; BINDING SITE; BIPOLAR I DISORDER; CADAVER; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LIGAND BINDING; PRIORITY JOURNAL; SCHIZOPHRENIA; BINDING COMPETITION; BIPOLAR DISORDER; BRAIN LEVEL; DRUG EFFECT; FEMALE; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOASSAY;

ADULT; AGED; BINDING, COMPETITIVE; BIPOLAR DISORDER; BRAIN CHEMISTRY; CLONAZEPAM; FEMALE; FLUMAZENIL; GABA AGONISTS; GABA MODULATORS; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; MUSCIMOL; PROTEIN SUBUNITS; PYRIDINES; RADIOLIGAND ASSAY; RECEPTORS, GABA-A; SCHIZOPHRENIA;

EID: 23744446308     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2005.04.005     Document Type: Article

References (43)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994 American Psychiatric Association Washington, DC
2. F. Araujo, D. Ruano, and J. Vitorica Native gamma-aminobutyric acid type A receptors from rat hippocampus, containing both alpha 1 and alpha 5 subunits, exhibit a single benzodiazepine binding site with alpha 5 pharmacological properties J. Pharmacol. Exp. Ther. 290 1999 989 997
3. F.M. Benes, Y. Khan, S.L. Vincent, and R. Wickramasinghe Differences in the subregional and cellular distribution of GABAA receptor binding in the hippocampal formation of schizophrenic brain Synapse 22 1996 338 349
4. F.M. Benes, R. Wickramasinghe, S.L. Vincent, Y. Khan, and M. Todtenkopf Uncoupling of GABA(A) and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain Brain Res. 755 1997 121 129
5. K.Z. Bezchlibnyk-Butler, and J.J. Jeffries Clinical Handbook of Psychotropic Drugs 1999 Hogrefe and Huber Publishers Toronto
6. J. Bormann The 'ABC' of GABA receptors Trends Pharmacol. Sci. 21 2000 16 19
7. M. Canonaco, L.H. O'Connor, D.W. Pfaff, and B.S. McEwen GABA[A] receptor level changes in female hamster forebrain following in vivo estrogen progesterone and benzodiazepine treatment: a quantitative autoradiography analysis Exp. Brain Res. 75 1989 644 652
8. M. Chebib, and G.A. Johnston The 'ABC' of GABA receptors: a brief review Clin. Exp. Pharmacol. Physiol. 26 1999 937 940
9. N. Collinson, F.M. Kuenzi, W. Jarolimek, K.A. Maubach, R. Cothliff, C. Sur, A. Smith, F.M. Otu, O. Howell, J.R. Atack, R.M. McKernan, G.R. Seabrook, G.R. Dawson, P.J. Whiting, and T.W. Rosahl Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor J. Neurosci. 22 2002 5572 5580
10. P.B. Crino, A.C. Duhaime, G. Baltuch, and R. White Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia Neurology 56 2001 906 913
11. B. Dean, T. Hussain, W. Hayes, E. Scarr, S. Kitsoulis, C. Hill, K. Opeskin, and D.L. Copolov Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex J. Neurochem. 72 1999 1593 1599
12. A. De Bruyn, D. Souery, K. Mendelbaum, J. Mendlewicz, and C. Van Broeckhoven A linkage study between bipolar disorder and genes involved in dopaminergic and GABAergic neurotransmission Psychiatr. Genet. 6 1996 67 73
13. S.C. Dilsaver, Y.R. Chen, A.M. Shoaib, and A.C. Swann Phenomenology of mania: evidence for distinct depressed, dysphoric, and euphoric presentations Am. J. Psychiatry 156 1999 426 430
14. H. Ewald, O. Mors, T. Flint, and T.A. Kruse Linkage analysis between manic-depressive illness and the region on chromosome 15q involved in Prader-Willi syndrome, including two GABAA receptor subtype genes Hum. Hered. 44 1994 287 294
15. D. Farnbach-Pralong, R. Bradbury, D. Copolov, and B. Dean Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors Eur. J. Pharmacol. 349 1998 R7 R8
16. P. Foster Neuroleptic equivalence Pharmacol. J. 243 1989 431 432
17. M. Heaulme, J.P. Chambon, R. Leyris, J.C. Molimard, C.G. Wermuth, and K. Biziere Biochemical characterization of the interaction of three pyridazinyl-GABA derivatives with the GABAA receptor site Brain Res. 384 1986 224 231
18. S. Heckers, D. Stone, J. Walsh, J. Shick, P. Koul, and F.M. Benes Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia Arch. Gen. Psychiatry 59 2002 521 529
19. C. Hill, N. Keks, S. Roberts, K. Opeskin, B. Dean, and D. Copolov Diagnostic Instrument for Brain Studies 1999 Mental Health Research Institute Melbourne
20. C.L. Huang, C.J. Chang, C.F. Hung, and H.Y. Lin Zolpidem-induced distortion in visual perception Ann. Pharmacother. 37 2003 683 686
21. E.C. Johnstone, T.J. Crow, C.D. Frith, and D.G. Owens The Northwick Park "functional" psychosis study: diagnosis and treatment response Lancet 2 1988 119 125
22. A.E. Kingsbury, O.J. Foster, A.P. Nisbet, N. Cairns, L. Bray, D.J. Eve, A.J. Lees, and C.D. Marsden Tissue pH as an indicator of mRNA preservation in human post-mortem brain Brain Res. Mol. Brain Res. 28 1995 311 318
23. Y. Kiuchi, T. Kobayashi, J. Takeuchi, H. Shimizu, H. Ogata, and M. Toru Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics Eur. Arch. Psychiatr. Neurol. Sci. 239 1989 71 78
24. G.T. Liberatore, J.Y. Wong, D. Krenus, B.J. Jeffreys, M.J. Porritt, and D.W. Howells Tissue fixation prevents contamination of tritium-sensitive storage phosphor imaging plates Biotechniques 26 1999 432 434
25. A. Lingford-Hughes, S.P. Hume, A. Feeney, E. Hirani, S. Osman, V.J. Cunningham, V.W. Pike, D.J. Brooks, and D.J. Nutt Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomography J. Cereb. Blood Flow Metab. 22 2002 878 889
26. F. Loup, H.G. Wieser, Y. Yonekawa, A. Aguzzi, and J.M. Fritschy Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy J. Neurosci. 20 2000 5401 5419
27. J. Maeda, T. Suhara, K. Kawabe, T. Okauchi, S. Obayashi, J. Hojo, and K. Suzuki Visualization of alpha5 subunit of GABAA/benzodiazepine receptor by 11C Ro15-4513 using positron emission tomography Synapse 47 2003 200 208
28. P.J. Marangos, and J.N. Crawley Chronic benzodiazepine treatment increases [3H]muscimol binding in mouse brain Neuropharmacology 21 1982 81 84
29. K. Maubach GABA(A) receptor subtype selective cognition enhancers Curr. Drug Targets CNS. Neurol. Disord. 2 2003 233 239
30. M. McLeod, D. Pralong, D. Copolov, and B. Dean The heterogeneity of central benzodiazepine receptor subtypes in the human hippocampal formation, frontal cortex and cerebellum using [3H]flumazenil and zolpidem Brain Res. Mol. Brain Res. 104 2002 203 209
31. K. Mizukami, D.R. Grayson, M.D. Ikonomovic, R. Sheffield, and D.M. Armstrong GABAA receptor beta 2 and beta 3 subunits mRNA in the hippocampal formation of aged human brain with Alzheimer-related neuropathology Brain Res. Mol. Brain Res. 56 1998 268 272
32. G.N. Papadimitriou, D.G. Dikeos, G. Karadima, D. Avramopoulos, E.G. Daskalopoulou, D. Vassilopoulos, and C.N. Stefanis Association between the GABA(A) receptor alpha5 subunit gene locus (GABRA5) and bipolar affective disorder Am. J. Med. Genet. 81 1998 73 80
33. G.N. Papadimitriou, D.G. Dikeos, G. Karadima, D. Avramopoulos, E.G. Daskalopoulou, and C.N. Stefanis GABA-A receptor beta3 and alpha5 subunit gene cluster on chromosome 15q11-q13 and bipolar disorder: a genetic association study Am. J. Med. Genet. 105 2001 317 320
34. S. Quraishi, and S. Frangou Neuropsychology of bipolar disorder: a review J. Affect. Disord. 72 2002 209 226
35. G.P. Reynolds, and D. Stroud Hippocampal benzodiazepine receptors in schizophrenia J. Neural Transm.: Gen. Sect. 93 1993 151 155
36. D. Rodbard Lessons from the computerization of radioimmunoassays: an introduction to basic principles of modelling D. Rodbard G. Forti Computers and Endocrinology 1984 Raven Press New York
37. J.S. Rubinsztein, and B.J. Sahakian Cognitive impairment in bipolar disorder Br. J. Psychiatry 181 2002 440
38. S.M. Sanabria-Bohorquez, A.G. De Volder, P. Arno, M. Sibomana, A. Coppens, C. Michel, and C. Veraart Decreased benzodiazepine receptor density in the cerebellum of early blind human subjects Brain Res. 888 2001 203 211
39. A and dopamine D1 binding sites correlates of haloperidol-induced oral dyskinesias in rat Exp. Neurol. 127 1994 62 69
40. E. Sigel, and A. Buhr The benzodiazepine binding site of GABAA receptors Trends Pharmacol. Sci. 18 1997 425 429
41. J.C. Soares, and R.B. Innis Neurochemical brain imaging investigations of schizophrenia Biol. Psychiatry 46 1999 600 615
42. R.F. Squires, A. Lajtha, E. Saederup, and M. Palkovits Reduced [3H]flunitrazepam binding in cingulate cortex and hippocampus of postmortem schizophrenic brains: is selective loss of glutamatergic neurons associated with major psychoses? Neurochem. Res. 18 1993 219 223
43. E.F. Torrey, M. Webster, M. Knable, N. Johnston, and R.H. Yolken The Stanley foundation brain collection and neuropathology consortium Schizophr. Res. 44 2000 151 155